Shamrock Industrial Company Ltd

Shamrock Industrial Company Limited — Closure of trading window from close of trading hours September 30, 2026 until 48 hours after the announcement of the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2026.

AGM notice and email registration

• AGM scheduled for Sept 30, 2026 at 3:00 PM IST via VC/OAVM.
• Letters sent to shareholders without registered emails per Regulation 36(1)(b).
• Notice and annual report accessible via a web link.
• Shareholders urged to update email addresses to receive future communications.

Financial snapshot

• Revenue from operations NIL for FY 2025-26.
• Total revenue reported at ₹2.58 lakh, via other income.
• Net loss after tax ₹108.66 lakh for FY 2025-26.
• EPS per Director's Report shows (2) Rs; Note 19 shows 2.00 Rs.

Capital structure & dividends

• Authorized capital increased to ₹40 crore.
• Subscribed and paid-up equity capital ₹5.4284 crore.
• Dividend not declared due to losses.

Operations & revival plan

• Company remained non-operational; revival under evaluation.
• New object added for Virtual Digital Assets; no activity in year.

Management & governance changes

• New MD/CEO appointment during year; Oct 16, 2025.
• CFO changed; Rahul Manoj Rajani appointed Oct 16, 2025.

Audit, internal controls & governance

• Statutory auditors changed to Motilal & Associates LLP; Dec 11, 2025.
• MR-3 notes occasional gaps; management undertaking corrective steps.

Risks & outlook

• Pharma-sector risks include regulatory, pricing pressures.
• Outlook focused on revival, cost control, and potential profitability.

AGM & shareholder information

• 35th AGM on Sept 30, 2026 via VC/OAVM.
• Cut-off date: Sept 23, 2026; remote e-voting Sept 27-29, 2026.
• Dividend status unchanged; annual report available on company site.

Related party transactions

• Significant related party loans; ₹82.04 lakh outstanding to Shamrock Pharmachemi Pvt. Ltd. (as at year-end).
• Other related-party balances and transactions disclosed in notes.

Audit opinion & Internal controls

• Auditors issued unqualified opinion on financial statements.
• Internal financial controls deemed adequate and operating effectively.

Financial results approved

• Standalone unaudited Q1 2026 results approved with Limited Review Report.

Key financials

• Total income 2.58 lakh; net loss 10.22 lakh; EPS -0.19.

Auditor review

• Independent auditor's review concluded no material misstatement; report not modified.

Accounting framework

• Results prepared under IND AS; prior periods restated as needed.

Board process

• Results reviewed by Audit Committee; approved by Board on 14 Aug 2026.

Other notes

• Prior period figures regrouped/reclassified where necessary.

Regulatory/compliance

• SEBI LODR compliance for quarter ended 30 Jun 2026.

Meeting Details

• Board meeting scheduled for Friday, August 14, 2026 (time and venue not disclosed).

Key Agenda Items

• Consider unaudited standalone financial results for quarter ended June 30, 2026.
• Note compliance status for quarter ended June 30, 2026 under SEBI LODR.

Other Notes

• Trading window closed from June 30, 2026 till 48 hours after the unaudited results.